Cogent Biosciences Chief Medical Officer Jessica Sachs' 2021 pay jumps 220% to $3.8M

Cogent Biosciences reports 2021 executive compensation

By ExecPay News

Published: April 26, 2022

Cogent Biosciences reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, three executives at Cogent Biosciences received on average a compensation package of $3.4M, a 64% decrease compared to previous year.
Average pay of disclosed executives at Cogent Biosciences
Jessica Sachs, Chief Medical Officer, received $3.8M in total, which increased by 220% compared to 2020. 84% of Sachs' compensation, or $3.2M, was in option awards. Sachs also received $168K in bonus, $416K in salary, as well as $12K in other compensation.
John Robinson, Chief Scientific Officer, received a compensation package of $3.5M. 87% of the compensation package, or $3M, was in option awards.
Andrew Robbins, Chief Executive Officer, earned $2.9M in 2021, a 84% decrease compared to previous year.

Related executives

Andrew Robbins

Cogent Biosciences

Chief Executive Officer

Jessica Sachs

Cogent Biosciences

Chief Medical Officer

John Robinson

Cogent Biosciences

Chief Scientific Officer

You may also like

Source: SEC filing on April 26, 2022.